These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 21068143)
1. Donor pre-treatment with everolimus or cyclosporine does not reduce ischaemia-reperfusion injury in a rat kidney transplant model. Martinez-Palli G; Hirose R; Liu T; Xu F; Dang K; Feiner J; Serkova NJ; Niemann CU Nephrol Dial Transplant; 2011 Jun; 26(6):1813-20. PubMed ID: 21068143 [TBL] [Abstract][Full Text] [Related]
2. Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation. Lobb I; Mok A; Lan Z; Liu W; Garcia B; Sener A BJU Int; 2012 Dec; 110(11 Pt C):E1187-95. PubMed ID: 23157304 [TBL] [Abstract][Full Text] [Related]
3. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Fuller TF; Freise CE; Serkova N; Niemann CU; Olson JL; Feng S Transplantation; 2003 Dec; 76(11):1594-9. PubMed ID: 14702530 [TBL] [Abstract][Full Text] [Related]
4. Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction. Zhu JX; Kalbfleisch M; Yang YX; Bihari R; Lobb I; Davison M; Mok A; Cepinskas G; Lawendy AR; Sener A BJU Int; 2012 Dec; 110(11 Pt C):E1218-27. PubMed ID: 23046222 [TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic allograft nephropathy at late stages using everolimus or FTY720 in combination with cyclosporine. Roos M; Liu S; Strobl M; Schmaderer C; Baumann M; Heemann U; Lutz J Transplant Proc; 2008 Dec; 40(10):3731-6. PubMed ID: 19100477 [TBL] [Abstract][Full Text] [Related]
6. Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Shihab FS; Bennett WM; Andoh TF Transplantation; 2009 Feb; 87(3):326-9. PubMed ID: 19202436 [TBL] [Abstract][Full Text] [Related]
7. Everolimus and reduced cyclosporine trough levels in maintenance heart transplant recipients. Schweiger M; Wasler A; Prenner G; Stiegler P; Stadlbauer V; Schwarz M; Tscheliessnigg K Transpl Immunol; 2006 Jun; 16(1):46-51. PubMed ID: 16701176 [TBL] [Abstract][Full Text] [Related]
16. Glutamine donor pretreatment in rat kidney transplants with severe preservation reperfusion injury. Fuller TF; Rose F; Singleton KD; Linde Y; Hoff U; Freise CE; Dragun D; Niemann CU J Surg Res; 2007 Jun; 140(1):77-83. PubMed ID: 17292409 [TBL] [Abstract][Full Text] [Related]
17. Everolimus with reduced-dose cyclosporine in de novo renal transplant recipients: Philippine experience. Li JT; Danguilan RA; Cabanayan-Casasola CB; Talusan-Tomacruz Y; Ona ET Transplant Proc; 2008 Sep; 40(7):2211-3. PubMed ID: 18790195 [TBL] [Abstract][Full Text] [Related]
18. [Immunosuppression in kidney donors with rapamycin and tacrolimus. Proinflammatory cytokine expression]. Cicora F; Roberti J; Lausada N; González P; Guerrieri D; Stringa P; Raimondi C Medicina (B Aires); 2012; 72(1):3-9. PubMed ID: 22257448 [TBL] [Abstract][Full Text] [Related]
19. Conversion of stable kidney transplant recipients from a twice-daily to once-daily everolimus regimen. Carmellini M; Collini A; Ruggieri G; Bernini M Transplant Proc; 2010 May; 42(4):1312-3. PubMed ID: 20534288 [TBL] [Abstract][Full Text] [Related]
20. Sirolimus-based therapy with or without cyclosporine: long-term follow-up in renal transplant patients. Morales JM; Campistol JM; Kreis H; Mourad G; Eris J; Schena FP; Grinyo JM; Nanni G; Andres A; Castaing N; Brault Y; Burke JT Transplant Proc; 2005 Mar; 37(2):693-6. PubMed ID: 15848504 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]